Nicotine and D-cycloserine enhance acquisition of water maze spatial navigation in aged rats
- 10 February 1997
- journal article
- ageing
- Published by Wolters Kluwer Health in NeuroReport
- Vol. 8 (3) , 699-703
- https://doi.org/10.1097/00001756-199702100-00024
Abstract
WE investigated the effect of nicotine, a nicotinic agonist, and D-cycloserine (DCS, a partial glycine-B agonist of the N-methyl-D-aspartate (NMDA) receptor complex) on aging-induced defects of water maze (WM) spatial navigation in rats. Nicotine (0.3 mg kg−1, s.c.) or DCS (10 mg kg−1, i.p.) enhanced acquisition of the WM task. A combination of subthreshold doses of nicotine (0.1 mg kg−1) and DCS (3 mg kg−1) improved WM acquisition. A subthreshold dose of a competitive NMDA antagonist, CPP (1 mg kg−1), blocked the effect of nicotine (0.3 mg kg−1) on WM acquisition. A nicotine antagonist, mecamylamine (10 mg kg−1), impaired WM acquisition and had no effect on retention, but did not block the effect of DCS 10 mg kg−1. The results suggest that nicotine and DCS synergistically enhance spatial navigation in aged rats.Keywords
This publication has 8 references indexed in Scilit:
- Pharmacology of memory: cholinergic—glutamatergic interactionsCurrent Opinion in Neurobiology, 1995
- Modulation of cellular excitability in neocortex: Muscarinic receptor and second messenger‐mediated actions of acetylcholineSynapse, 1994
- Normal aging: regionally specific changes in hippocampal synaptic transmissionTrends in Neurosciences, 1994
- Animal models of Alzheimer's disease: Glutamatergic denervation as an alternative approach to cholinergic denervationNeuroscience & Biobehavioral Reviews, 1993
- Synapse loss in the temporal lobe in Alzheimer's diseaseAnnals of Neurology, 1993
- A synaptic model of memory: long-term potentiation in the hippocampusNature, 1993
- Agonists of cholinergic and noradrenergic receptors facilitate synergistically the induction of long-term potentiation in slices of rat visual cortexBrain Research, 1992
- Competitive antagonism of glycine at the N-methyl-d-aspartate (NMDA) receptorBiochemical Pharmacology, 1991